The global market for Denosumab Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Denosumab injection is a medication used primarily to treat bone-related conditions such as osteoporosis, particularly in patients at high risk of fractures, as well as for bone loss associated with cancer.

North American market for Denosumab Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Denosumab Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Denosumab Injection include Amgen, Sandoz Biologics, Amneal, Fresenius Kabi, Dr. Reddy's Laboratories, Alvotech, Lotus Pharmaceutical, Intas Pharmaceuticals, Qilu Pharmaceutical, Jiangsu T-mab BioPharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Denosumab Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Denosumab Injection.

The Denosumab Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Denosumab Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Denosumab Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Denosumab Injection Market Report

Report Metric	Details
Report Name	Denosumab Injection Market
Segment by Type	60mg per Vial 120mg per Vial
Segment by Application	Giant Cell Tumor of Bone Multiple Myeloma Hypercalcemia of Malignant Tumors Osteolytic Bone Metastasis of Solid Tumors
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Amgen, Sandoz Biologics, Amneal, Fresenius Kabi, Dr. Reddy's Laboratories, Alvotech, Lotus Pharmaceutical, Intas Pharmaceuticals, Qilu Pharmaceutical, Jiangsu T-mab BioPharma, Boan Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Denosumab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Denosumab Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Denosumab Injection Market report?

Ans: The main players in the Denosumab Injection Market are Amgen, Sandoz Biologics, Amneal, Fresenius Kabi, Dr. Reddy's Laboratories, Alvotech, Lotus Pharmaceutical, Intas Pharmaceuticals, Qilu Pharmaceutical, Jiangsu T-mab BioPharma, Boan Biotech

What are the Application segmentation covered in the Denosumab Injection Market report?

Ans: The Applications covered in the Denosumab Injection Market report are Giant Cell Tumor of Bone, Multiple Myeloma, Hypercalcemia of Malignant Tumors, Osteolytic Bone Metastasis of Solid Tumors

What are the Type segmentation covered in the Denosumab Injection Market report?

Ans: The Types covered in the Denosumab Injection Market report are 60mg per Vial, 120mg per Vial

1 Denosumab Injection Market Overview

1.1 Product Definition

1.2 Denosumab Injection by Type

1.2.1 Global Denosumab Injection Market Value Comparison by Type (2024 VS 2031)

1.2.2 60mg per Vial

1.2.3 120mg per Vial

1.3 Denosumab Injection by Application

1.3.1 Global Denosumab Injection Market Value by Application (2024 VS 2031)

1.3.2 Giant Cell Tumor of Bone

1.3.3 Multiple Myeloma

1.3.4 Hypercalcemia of Malignant Tumors

1.3.5 Osteolytic Bone Metastasis of Solid Tumors

1.4 Global Denosumab Injection Market Size Estimates and Forecasts

1.4.1 Global Denosumab Injection Revenue 2020-2031

1.4.2 Global Denosumab Injection Sales 2020-2031

1.4.3 Global Denosumab Injection Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Denosumab Injection Market Competition by Manufacturers

2.1 Global Denosumab Injection Sales Market Share by Manufacturers (2020-2025)

2.2 Global Denosumab Injection Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Denosumab Injection Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Denosumab Injection, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Denosumab Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Denosumab Injection, Product Type & Application

2.7 Global Key Manufacturers of Denosumab Injection, Date of Enter into This Industry

2.8 Global Denosumab Injection Market Competitive Situation and Trends

2.8.1 Global Denosumab Injection Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Denosumab Injection Players Market Share by Revenue

2.8.3 Global Denosumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Denosumab Injection Market Scenario by Region

3.1 Global Denosumab Injection Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Denosumab Injection Sales by Region: 2020-2031

3.2.1 Global Denosumab Injection Sales by Region: 2020-2025

3.2.2 Global Denosumab Injection Sales by Region: 2026-2031

3.3 Global Denosumab Injection Revenue by Region: 2020-2031

3.3.1 Global Denosumab Injection Revenue by Region: 2020-2025

3.3.2 Global Denosumab Injection Revenue by Region: 2026-2031

3.4 North America Denosumab Injection Market Facts & Figures by Country

3.4.1 North America Denosumab Injection Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Denosumab Injection Sales by Country (2020-2031)

3.4.3 North America Denosumab Injection Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Denosumab Injection Market Facts & Figures by Country

3.5.1 Europe Denosumab Injection Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Denosumab Injection Sales by Country (2020-2031)

3.5.3 Europe Denosumab Injection Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Denosumab Injection Market Facts & Figures by Region

3.6.1 Asia Pacific Denosumab Injection Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Denosumab Injection Sales by Region (2020-2031)

3.6.3 Asia Pacific Denosumab Injection Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Denosumab Injection Market Facts & Figures by Country

3.7.1 Latin America Denosumab Injection Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Denosumab Injection Sales by Country (2020-2031)

3.7.3 Latin America Denosumab Injection Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Denosumab Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Denosumab Injection Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Denosumab Injection Sales by Country (2020-2031)

3.8.3 Middle East and Africa Denosumab Injection Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Denosumab Injection Sales by Type (2020-2031)

4.1.1 Global Denosumab Injection Sales by Type (2020-2025)

4.1.2 Global Denosumab Injection Sales by Type (2026-2031)

4.1.3 Global Denosumab Injection Sales Market Share by Type (2020-2031)

4.2 Global Denosumab Injection Revenue by Type (2020-2031)

4.2.1 Global Denosumab Injection Revenue by Type (2020-2025)

4.2.2 Global Denosumab Injection Revenue by Type (2026-2031)

4.2.3 Global Denosumab Injection Revenue Market Share by Type (2020-2031)

4.3 Global Denosumab Injection Price by Type (2020-2031)

5 Segment by Application

5.1 Global Denosumab Injection Sales by Application (2020-2031)

5.1.1 Global Denosumab Injection Sales by Application (2020-2025)

5.1.2 Global Denosumab Injection Sales by Application (2026-2031)

5.1.3 Global Denosumab Injection Sales Market Share by Application (2020-2031)

5.2 Global Denosumab Injection Revenue by Application (2020-2031)

5.2.1 Global Denosumab Injection Revenue by Application (2020-2025)

5.2.2 Global Denosumab Injection Revenue by Application (2026-2031)

5.2.3 Global Denosumab Injection Revenue Market Share by Application (2020-2031)

5.3 Global Denosumab Injection Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Amgen

6.1.1 Amgen Company Information

6.1.2 Amgen Description and Business Overview

6.1.3 Amgen Denosumab Injection Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Amgen Denosumab Injection Product Portfolio

6.1.5 Amgen Recent Developments/Updates

6.2 Sandoz Biologics

6.2.1 Sandoz Biologics Company Information

6.2.2 Sandoz Biologics Description and Business Overview

6.2.3 Sandoz Biologics Denosumab Injection Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Sandoz Biologics Denosumab Injection Product Portfolio

6.2.5 Sandoz Biologics Recent Developments/Updates

6.3 Amneal

6.3.1 Amneal Company Information

6.3.2 Amneal Description and Business Overview

6.3.3 Amneal Denosumab Injection Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Amneal Denosumab Injection Product Portfolio

6.3.5 Amneal Recent Developments/Updates

6.4 Fresenius Kabi

6.4.1 Fresenius Kabi Company Information

6.4.2 Fresenius Kabi Description and Business Overview

6.4.3 Fresenius Kabi Denosumab Injection Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Fresenius Kabi Denosumab Injection Product Portfolio

6.4.5 Fresenius Kabi Recent Developments/Updates

6.5 Dr. Reddy's Laboratories

6.5.1 Dr. Reddy's Laboratories Company Information

6.5.2 Dr. Reddy's Laboratories Description and Business Overview

6.5.3 Dr. Reddy's Laboratories Denosumab Injection Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Dr. Reddy's Laboratories Denosumab Injection Product Portfolio

6.5.5 Dr. Reddy's Laboratories Recent Developments/Updates

6.6 Alvotech

6.6.1 Alvotech Company Information

6.6.2 Alvotech Description and Business Overview

6.6.3 Alvotech Denosumab Injection Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Alvotech Denosumab Injection Product Portfolio

6.6.5 Alvotech Recent Developments/Updates

6.7 Lotus Pharmaceutical

6.7.1 Lotus Pharmaceutical Company Information

6.7.2 Lotus Pharmaceutical Description and Business Overview

6.7.3 Lotus Pharmaceutical Denosumab Injection Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Lotus Pharmaceutical Denosumab Injection Product Portfolio

6.7.5 Lotus Pharmaceutical Recent Developments/Updates

6.8 Intas Pharmaceuticals

6.8.1 Intas Pharmaceuticals Company Information

6.8.2 Intas Pharmaceuticals Description and Business Overview

6.8.3 Intas Pharmaceuticals Denosumab Injection Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Intas Pharmaceuticals Denosumab Injection Product Portfolio

6.8.5 Intas Pharmaceuticals Recent Developments/Updates

6.9 Qilu Pharmaceutical

6.9.1 Qilu Pharmaceutical Company Information

6.9.2 Qilu Pharmaceutical Description and Business Overview

6.9.3 Qilu Pharmaceutical Denosumab Injection Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Qilu Pharmaceutical Denosumab Injection Product Portfolio

6.9.5 Qilu Pharmaceutical Recent Developments/Updates

6.10 Jiangsu T-mab BioPharma

6.10.1 Jiangsu T-mab BioPharma Company Information

6.10.2 Jiangsu T-mab BioPharma Description and Business Overview

6.10.3 Jiangsu T-mab BioPharma Denosumab Injection Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Jiangsu T-mab BioPharma Denosumab Injection Product Portfolio

6.10.5 Jiangsu T-mab BioPharma Recent Developments/Updates

6.11 Boan Biotech

6.11.1 Boan Biotech Company Information

6.11.2 Boan Biotech Description and Business Overview

6.11.3 Boan Biotech Denosumab Injection Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Boan Biotech Denosumab Injection Product Portfolio

6.11.5 Boan Biotech Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Denosumab Injection Industry Chain Analysis

7.2 Denosumab Injection Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Denosumab Injection Production Mode & Process Analysis

7.4 Denosumab Injection Sales and Marketing

7.4.1 Denosumab Injection Sales Channels

7.4.2 Denosumab Injection Distributors

7.5 Denosumab Injection Customer Analysis

8 Denosumab Injection Market Dynamics

8.1 Denosumab Injection Industry Trends

8.2 Denosumab Injection Market Drivers

8.3 Denosumab Injection Market Challenges

8.4 Denosumab Injection Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Dr. Reddy’s Laboratories

Alvotech

Lotus Pharmaceutical

Intas Pharmaceuticals

Qilu Pharmaceutical

Boan Biotech

Sandoz Biologics

Jiangsu T-mab BioPharma

Amgen Inc

Amneal

Fresenius Kabi

List of Tables

Table 1. Global Denosumab Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Denosumab Injection Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Denosumab Injection Market Competitive Situation by Manufacturers in 2024

Table 4. Global Denosumab Injection Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Denosumab Injection Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Denosumab Injection Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Denosumab Injection Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Denosumab Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Denosumab Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Denosumab Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Denosumab Injection, Product Type & Application

Table 12. Global Key Manufacturers of Denosumab Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Denosumab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Denosumab Injection as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Denosumab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Denosumab Injection Sales by Region (2020-2025) & (K Units)

Table 18. Global Denosumab Injection Sales Market Share by Region (2020-2025)

Table 19. Global Denosumab Injection Sales by Region (2026-2031) & (K Units)

Table 20. Global Denosumab Injection Sales Market Share by Region (2026-2031)

Table 21. Global Denosumab Injection Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Denosumab Injection Revenue Market Share by Region (2020-2025)

Table 23. Global Denosumab Injection Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Denosumab Injection Revenue Market Share by Region (2026-2031)

Table 25. North America Denosumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Denosumab Injection Sales by Country (2020-2025) & (K Units)

Table 27. North America Denosumab Injection Sales by Country (2026-2031) & (K Units)

Table 28. North America Denosumab Injection Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Denosumab Injection Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Denosumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Denosumab Injection Sales by Country (2020-2025) & (K Units)

Table 32. Europe Denosumab Injection Sales by Country (2026-2031) & (K Units)

Table 33. Europe Denosumab Injection Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Denosumab Injection Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Denosumab Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Denosumab Injection Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Denosumab Injection Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Denosumab Injection Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Denosumab Injection Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Denosumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Denosumab Injection Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Denosumab Injection Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Denosumab Injection Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Denosumab Injection Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Denosumab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Denosumab Injection Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Denosumab Injection Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Denosumab Injection Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Denosumab Injection Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Denosumab Injection Sales (K Units) by Type (2020-2025)

Table 51. Global Denosumab Injection Sales (K Units) by Type (2026-2031)

Table 52. Global Denosumab Injection Sales Market Share by Type (2020-2025)

Table 53. Global Denosumab Injection Sales Market Share by Type (2026-2031)

Table 54. Global Denosumab Injection Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Denosumab Injection Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Denosumab Injection Revenue Market Share by Type (2020-2025)

Table 57. Global Denosumab Injection Revenue Market Share by Type (2026-2031)

Table 58. Global Denosumab Injection Price (US$/Unit) by Type (2020-2025)

Table 59. Global Denosumab Injection Price (US$/Unit) by Type (2026-2031)

Table 60. Global Denosumab Injection Sales (K Units) by Application (2020-2025)

Table 61. Global Denosumab Injection Sales (K Units) by Application (2026-2031)

Table 62. Global Denosumab Injection Sales Market Share by Application (2020-2025)

Table 63. Global Denosumab Injection Sales Market Share by Application (2026-2031)

Table 64. Global Denosumab Injection Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Denosumab Injection Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Denosumab Injection Revenue Market Share by Application (2020-2025)

Table 67. Global Denosumab Injection Revenue Market Share by Application (2026-2031)

Table 68. Global Denosumab Injection Price (US$/Unit) by Application (2020-2025)

Table 69. Global Denosumab Injection Price (US$/Unit) by Application (2026-2031)

Table 70. Amgen Company Information

Table 71. Amgen Description and Business Overview

Table 72. Amgen Denosumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Amgen Denosumab Injection Product

Table 74. Amgen Recent Developments/Updates

Table 75. Sandoz Biologics Company Information

Table 76. Sandoz Biologics Description and Business Overview

Table 77. Sandoz Biologics Denosumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Sandoz Biologics Denosumab Injection Product

Table 79. Sandoz Biologics Recent Developments/Updates

Table 80. Amneal Company Information

Table 81. Amneal Description and Business Overview

Table 82. Amneal Denosumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Amneal Denosumab Injection Product

Table 84. Amneal Recent Developments/Updates

Table 85. Fresenius Kabi Company Information

Table 86. Fresenius Kabi Description and Business Overview

Table 87. Fresenius Kabi Denosumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Fresenius Kabi Denosumab Injection Product

Table 89. Fresenius Kabi Recent Developments/Updates

Table 90. Dr. Reddy's Laboratories Company Information

Table 91. Dr. Reddy's Laboratories Description and Business Overview

Table 92. Dr. Reddy's Laboratories Denosumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Dr. Reddy's Laboratories Denosumab Injection Product

Table 94. Dr. Reddy's Laboratories Recent Developments/Updates

Table 95. Alvotech Company Information

Table 96. Alvotech Description and Business Overview

Table 97. Alvotech Denosumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Alvotech Denosumab Injection Product

Table 99. Alvotech Recent Developments/Updates

Table 100. Lotus Pharmaceutical Company Information

Table 101. Lotus Pharmaceutical Description and Business Overview

Table 102. Lotus Pharmaceutical Denosumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Lotus Pharmaceutical Denosumab Injection Product

Table 104. Lotus Pharmaceutical Recent Developments/Updates

Table 105. Intas Pharmaceuticals Company Information

Table 106. Intas Pharmaceuticals Description and Business Overview

Table 107. Intas Pharmaceuticals Denosumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Intas Pharmaceuticals Denosumab Injection Product

Table 109. Intas Pharmaceuticals Recent Developments/Updates

Table 110. Qilu Pharmaceutical Company Information

Table 111. Qilu Pharmaceutical Description and Business Overview

Table 112. Qilu Pharmaceutical Denosumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Qilu Pharmaceutical Denosumab Injection Product

Table 114. Qilu Pharmaceutical Recent Developments/Updates

Table 115. Jiangsu T-mab BioPharma Company Information

Table 116. Jiangsu T-mab BioPharma Description and Business Overview

Table 117. Jiangsu T-mab BioPharma Denosumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Jiangsu T-mab BioPharma Denosumab Injection Product

Table 119. Jiangsu T-mab BioPharma Recent Developments/Updates

Table 120. Boan Biotech Company Information

Table 121. Boan Biotech Description and Business Overview

Table 122. Boan Biotech Denosumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Boan Biotech Denosumab Injection Product

Table 124. Boan Biotech Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Denosumab Injection Distributors List

Table 128. Denosumab Injection Customers List

Table 129. Denosumab Injection Market Trends

Table 130. Denosumab Injection Market Drivers

Table 131. Denosumab Injection Market Challenges

Table 132. Denosumab Injection Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Denosumab Injection

Figure 2. Global Denosumab Injection Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Denosumab Injection Market Share by Type: 2024 & 2031

Figure 4. 60mg per Vial Product Picture

Figure 5. 120mg per Vial Product Picture

Figure 6. Global Denosumab Injection Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Denosumab Injection Market Share by Application: 2024 & 2031

Figure 8. Giant Cell Tumor of Bone

Figure 9. Multiple Myeloma

Figure 10. Hypercalcemia of Malignant Tumors

Figure 11. Osteolytic Bone Metastasis of Solid Tumors

Figure 12. Global Denosumab Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Denosumab Injection Market Size (2020-2031) & (US$ Million)

Figure 14. Global Denosumab Injection Sales (2020-2031) & (K Units)

Figure 15. Global Denosumab Injection Average Price (US$/Unit) & (2020-2031)

Figure 16. Denosumab Injection Report Years Considered

Figure 17. Denosumab Injection Sales Share by Manufacturers in 2024

Figure 18. Global Denosumab Injection Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Denosumab Injection Players: Market Share by Revenue in Denosumab Injection in 2024

Figure 20. Denosumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Denosumab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Denosumab Injection Sales Market Share by Country (2020-2031)

Figure 23. North America Denosumab Injection Revenue Market Share by Country (2020-2031)

Figure 24. United States Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Denosumab Injection Sales Market Share by Country (2020-2031)

Figure 27. Europe Denosumab Injection Revenue Market Share by Country (2020-2031)

Figure 28. Germany Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Denosumab Injection Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Denosumab Injection Revenue Market Share by Region (2020-2031)

Figure 35. China Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Denosumab Injection Sales Market Share by Country (2020-2031)

Figure 43. Latin America Denosumab Injection Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Denosumab Injection Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Denosumab Injection Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Denosumab Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Denosumab Injection by Type (2020-2031)

Figure 54. Global Revenue Market Share of Denosumab Injection by Type (2020-2031)

Figure 55. Global Denosumab Injection Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Denosumab Injection by Application (2020-2031)

Figure 57. Global Revenue Market Share of Denosumab Injection by Application (2020-2031)

Figure 58. Global Denosumab Injection Price (US$/Unit) by Application (2020-2031)

Figure 59. Denosumab Injection Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions